SXC Health Solutions announces $3.0 million software license agreement with the Province of British Columbia



    - Company to provide software for upgrade to  B.C. PharmaNet System -

    MILTON, ON, Jan. 10 /CNW/ - SXC Health Solutions Corp. ("SXC") (TSX: SXC,
NASDAQ:   SXCI), a leading provider of pharmacy benefits management ("PBM")
services and healthcare IT solutions to the healthcare benefits management
industry, announces a $3.0 million software license agreement with the
Ministry of Health in the Province of British Columbia ("B.C.") for an upgrade
to the Province's PharmaNet System. The agreement includes a license to use
SXC's Drug Information System ("DIS") solution. SXC's solution provides
government and commercial clients access to proven electronic medication
history management and state-of-the-art HL 7 Version 3 claims processing
technology.
    "We are pleased to have the opportunity to support the Ministry of Health
and the province in their effort to improve the quality of health care and
patient safety through this upgrade to PharmaNet," said Gordon Glenn, Chairman
and CEO of SXC. "This agreement strengthens our long standing relationship
with the Ministry, and affirms that our DIS product is suitable for any size
jurisdiction in Canada. We look forward to exploring opportunities to
participate in other DIS mandates across Canada."
    SXC's software will be the core processing engine for health record
transactions in the PharmaNet System. The software will add support for the
pan-Canadian Electronic Drug ("CeRx") Messaging Standard established under the
leadership of Canada Health Infoway Inc. ("Infoway"). Based in HL7 Version 3,
CeRx ensures that the software is transferable and interoperable in other
Canadian jurisdictions. This marks the second provincial licensing agreement
of SXC's DIS software applications with the first being on behalf of the
Province of Newfoundland and Labrador.

    About SXC Health Solutions Corp.

    SXC Health Solutions Corp. (formerly Systems Xcellence, Inc.) is a
leading provider of pharmacy benefits management (PBM) services and healthcare
IT solutions to the healthcare benefits management industry. The Company's
product offerings and solutions combine a wide range of software applications,
application service provider (ASP) processing services and professional
services, designed for many of the largest organizations in the pharmaceutical
supply chain, such as Federal, provincial, and, state and local governments,
pharmacy benefit managers, managed care organizations, retail pharmacy chains
and other healthcare intermediaries. SXC is based in Lisle, Illinois with
locations in; Scottsdale, Arizona; Warminster, Pennsylvania; Alpharetta,
Georgia; Milton, Ontario and Victoria, British Columbia. For more information
please visit www.sxc.com.

    Forward-Looking Statements

    Certain statements included herein, including those that express
management's expectations or estimates of our future performance, constitute
"forward-looking statements" within the meaning of applicable securities laws.
Forward-looking statements are necessarily based upon a number of estimates
and assumptions that, while considered reasonable by management at this time,
are inherently subject to significant business, economic and competitive
uncertainties and contingencies. We caution that such forward-looking
statements involve known and unknown risks, uncertainties and other risks that
may cause our actual financial results, performance, or achievements to be
materially different from our estimated future results, performance or
achievements expressed or implied by those forward-looking statements.
Numerous factors could cause actual results to differ materially from those in
the forward-looking statements, including without limitation, our ability to
achieve increased market acceptance for our product offerings and penetrate
new markets; consolidation in the healthcare industry; the existence of
undetected errors or similar problems in our software products; our ability to
identify and complete acquisitions, manage our growth and integrate
acquisitions; our ability to compete successfully; potential liability for the
use of incorrect or incomplete data; the length of the sales cycle for our
healthcare software solutions; interruption of our operations due to outside
sources; our dependence on key customers; maintaining our intellectual
property rights and litigation involving intellectual property rights; our
ability to obtain, use or successfully integrate third-party licensed
technology; compliance with existing laws, regulations and industry
initiatives and future change in laws or regulations in the healthcare
industry; breach of our security by third parties; our dependence on the
expertise of our key personnel; our access to sufficient capital to fund our
future requirements; and potential write-offs of goodwill or other intangible
assets. This list is not exhaustive of the factors that may affect any of our
forward-looking statements. Other factors that should be considered are
discussed from time to time in SXC's filings with the Canadian Securities
Administrators, including the risks and uncertainties discussed under Item 8,
Risk Factors in our Annual Information Form dated March 23, 2007, which is
available at www.sedar.com. Investors are cautioned not to put undue reliance
on forward-looking statements. All subsequent written and oral forward-looking
statements attributable to SXC or persons acting on our behalf are expressly
qualified in their entirety by this notice. We disclaim any intent or
obligation to update publicly these forward-looking statements, whether as a
result of new information, future events or otherwise. Risks and uncertainties
about our business are more fully discussed in our Annual Information Form.
    Certain of the assumptions made in preparing forward-looking information
and management's expectations include: maintenance of our existing customers
and contracts, our ability to market our products successfully to anticipated
customers, the impact of increasing competition, the growth of prescription
drug utilization rates at predicted levels, the retention of our key
personnel, our customers continuing to process transactions at historical
levels, that our systems will not be interrupted for any significant period of
time, that our products will perform free of major errors, our ability to
obtain financing on acceptable terms and that there will be no significant
changes in the regulation of our business.

    %SEDAR: 00001439E




For further information:

For further information: Jeff Park, Chief Financial Officer, SXC Health
Solutions, (630) 577-3206, investors@sxc.com; Dave Mason, Investor Relations,
The Equicom Group Inc., Tel: (416) 815-0700 ext. 237, dmason@equicomgroup.com;
Susan Noonan, Investor Relations - U.S., The SAN Group, LLC, (212) 966-3650,
susan@sanoonan.com

Organization Profile

Catamaran

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890